macrogenics.com - Utang kumulatif perusahaan MGNX

The prospects for MacroGenics, Inc. (MGNX) depend on immunotherapy results and licensing payments. The financial debt indicator visualizes the impact of borrowings on the share price, where 0.19 shows the level of this metric. Stability in drug production is ensured by its own plant in Maryland, while the efficiency of preclinical tests is enhanced through the implementation of AI-driven robotic systems.

MacroGenics, Inc. - Utang perusahaan MGNX (periode 04.07.2022 - 28.10.2026)

Rincian analitis lan laporan data perusahaan MacroGenics (MGNX)

- rega lan prakiraan konsensus rega:

Bagan owah-owahan rega MacroGenics Inc.|MGNX - Prakiraan konsensus analis

- data kapitalisasi pasar:

Nilai pasar MacroGenics Corp|MGNX - Nilai Perusahaan

- data kapitalisasi buku:

Nilai Buku saben Saham MacroGenics|MGNX - Nilai Buku Perusahaan|Kapitalisasi Pasar marang Nilai Buku macrogenics.com|MGNX - Gunggung Aset Perusahaan

- data utang lan likuiditas:

Utang Agregat marang Modal MacroGenics, Inc.|MGNX - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal MacroGenics Inc|MGNX - Gunggung utang perusahaan|Utang marang nilai buku MacroGenics Corp|MGNX - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan MacroGenics

Ringkesan analitik perusahaan:MGNX MacroGenics Inc.

To assess the long-term sustainability of MacroGenics, Inc. (MGNX), investors analyze the total volume of debt obligations, which measures the balance of borrowed loans and bonds relative to equity. This debt trend chart demonstrates the effectiveness of liquidity management, which is critical for the biopharmaceutical sector given its high R&D costs and reliance on strategic partnerships with big pharma behemoths.

Perusahaan pesaing

Kewajiban utang agregat Olema Corp (OLMA)|PBYI: Gunggung utang perusahaan|Utang kumulatif perusahaan greenwichlifesciences.com GLSI|Zentalis - Gunggung utang perusahaan|PSTV: Gunggung utang perusahaan|processapharmaceuticals.com - Utang perusahaan|Gunggung kewajiban utang perusahaan Eagle Pharmaceuticals, Inc.